Advertisement
Loading...

XOMA Royalty Corp.

XOMANASDAQ
Healthcare
Biotechnology
$41.65
$-0.17(-0.41%)
U.S. Market opens in 62h 44m

XOMA Royalty Corp. (XOMA) Stock Overview

Explore XOMA Royalty Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap522.3M
P/E Ratio15.79
EPS (TTM)$1.57
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$39.35
3 Months$37.10
1 Year Target$34.50

XOMA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of XOMA Royalty Corp. (XOMA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $34.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.79 and a market capitalization of 522.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.41%
5-Day Change
-0.45%
1-Month Change
5.79%
3-Month Change
61.37%
6-Month Change
31.18%
Year-to-Date (YTD) Change
56.64%
1-Year Change
65.87%
3-Year Change
114.58%
5-Year Change
41.19%
All-Time (Max) Change
-99.18%

Contact Information

510 204 7200
2200 Powell Street, EmeryVille, CA, 94608

Company Facts

13 Employees
IPO DateJun 6, 1986
CountryUS
Actively Trading

Frequently Asked Questions